Owl Therapeutics ("Owl"), a biopharmaceutical company developing drugs to supercharge microglia, the immune cells of the ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 –– Final analysis ...

Mutations in NPC1 cause Niemann-Pick Type C. Mice lacking NPC1 only in microglia have rampant neuroinflammation and impaired ...

ProNerve 6 Is a nerve health supplement designed to support optimal nerve function and overall neurological well-being.

A UB researcher working on Krabbe disease has been awarded a grant from the Rosenau Family Research Foundation to investigate how an enzyme deficiency in the brain causes this disease, which is ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A chronic gut infection caused by a common virus may be linked to the progression of Alzheimer ’s disease, a new study has ...

This study describes a valuable new model for in vivo manipulation of microglia, exploring how mutations in the Adar1 gene within microglia contribute to Aicardi-Goutières Syndome. The methodology is ...

Researchers have discovered a link between a chronic gut infection caused by a common virus and the development of ...

Researchers have identified a specific brain region in mice where aging triggers significant changes in numerous cell types.